ZenNews› Health› Medical Cannabis UK: Which Conditions Are Treated? Health Medical Cannabis UK: Which Conditions Are Treated? From chronic pain and PTSD to epilepsy — the full picture of NHS and private prescribing By ZenNews Editorial Apr 8, 2026 2 min read Updated: Jun 27, 2026 Medical cannabis has been legal in Great Britain since 2018 — but which conditions are actually treated, and what is the difference between what the NHS officially recommends and what private clinics prescribe every day?Table of ContentsThe Three Official NHS IndicationsWhat Private Clinics Treat: The Full SpectrumWhich Products Are Prescribed?Summary At a GlanceNHS approvals are limited to three specific conditions for medical cannabis.Private clinics widely treat a broader range of conditions, primarily chronic pain.Research is emerging on cannabis’s potential for anxiety, PTSD, and sleep disorders. The Three Official NHS Indications NICE has issued clear recommendations for cannabis prescribing at NHS level for only three conditions: Treatment-resistant epilepsy in children and adolescents — specifically Dravet syndrome and Lennox-Gastaut syndrome (Epidyolex, CBD-based) Nausea and vomiting caused by chemotherapy — where other antiemetics have failed (Nabilone, synthetic THC) Spasticity in multiple sclerosis — Sativex (THC/CBD oromucosal spray), available on NHS and privately Even within these three approved indications, prescribing on the NHS remains extremely rare. What Private Clinics Treat: The Full Spectrum Chronic Pain By far the most common indication at private clinics — approximately 70% of all patients. This includes neuropathic pain, back pain and spinal conditions, fibromyalgia, arthritis and rheumatic conditions, and chronic migraine. The video "Why is it so difficult to get medicinal cannabis in the UK? - BBC News" by BBC News provides background on this topic. It offers health-related insights that complement the article with visual material. Anxiety Disorders and PTSD CBD and low-THC preparations are used for anxiety disorders. Growing evidence supports cannabis for PTSD, particularly from research in Israel, Canada and the United States. UK private clinics are increasingly treating PTSD patients. Sleep Disorders Insomnia, particularly when combined with pain or anxiety, is one of the most common co-indications. Products with higher CBN content or indica-dominant cultivars are typically preferred. Multiple Sclerosis and Spasticity Already NHS-approved via Sativex, but also accessible through private clinics with a broader product range. Many MS patients report significant improvements in sleep quality and pain levels. Epilepsy: The Cases That Changed Everything Alfie Dingley: His family fought publicly for a cannabis licence and won one of the first NHS prescriptions in 2018. Billy Caldwell: A Northern Irish child whose cannabis oil imported from Canada was seized at customs — triggering the national debate that decisively accelerated the 2018 legalisation. Cancer Treatment and Nausea Nausea and appetite loss during cancer therapy are internationally among the best-evidenced indications. Palliative patients additionally benefit from the analgesic effects. ADHD A growing number of private clinics now treat adult ADHD patients, particularly those who cannot tolerate conventional stimulants. The evidence base remains limited but practitioner acceptance is growing. Which Products Are Prescribed? Product FormTypical IndicationNotes Dried flower (vaporised)Pain, sleep, PTSDMost common form in private clinics Oils / tincturesEpilepsy, anxietyPrecise dosing CapsulesChronic conditionsSlow onset, long-lasting effect Spray (Sativex)MS spasticityAvailable on NHS and privately Image: Leafme.co.uk Summary The gap between the three official NHS indications and the reality of private clinic prescribing is enormous. Anyone seeking access to medical cannabis in the UK will almost certainly need to pay privately, but gains access to a very broad range of treatment options. Further reading: Medical Cannabis UK — Complete Guide | Patient Information | Cannabis Law UK Explained Our TakeThis article clarifies the differing approaches to medical cannabis in the UK, highlighting NHS restrictions and private clinic expansion. It demonstrates the evolving landscape of research and treatment options for various conditions. Share Share X Facebook WhatsApp Copy link How do you feel about this? 🔥 0 😲 0 🤔 0 👍 0 😢 0 medical cannabis conditions chronic pain PTSD epilepsy NHS NICE UK clinics Z ZenNews Editorial Editorial The ZenNews editorial team covers the most important events from the US, UK and around the world around the clock — independent, reliable and fact-based. You might also like › Health Cancer Wait Times Test Starmer's NHS Turnaround Pledge 13 Sep 2026 Health Salmonella Egg Outbreak Tests UK's Food Import Safeguards 31 Aug 2026 Health Private ADHD Boom Tests NHS Diagnostic Oversight 30 Aug 2026 Health NHS Dentist Shortage Tests Access-to-Care Pledge 27 Aug 2026 Health Organ Transplant Backlog Tests NHS Equity Pledge 23 Aug 2026 Health Salmonella Egg Outbreak Tests UK's Import Food Safety Checks 21 Aug 2026 Health Hepatitis C Milestone Tests NHS Funding for Rare Diseases 19 Aug 2026 Health NHS Told to Plan for Heatwaves as It Does for Winter 16 Aug 2026 Also interesting › World Greenland Deal Puts UK Arctic Strategy Under Fresh Scrutiny 12 hrs ago UK Politics Wandsworth Tax Fight Tests Limits of Council Accountability Yesterday World Whitehall Reviews UK Infrastructure Defences Amid Russia Threat 18 Sep 2026 World Fed Rate Hike Pressures Bank of England on Borrowing Costs 17 Sep 2026 More in Health › Health Cancer Wait Times Test Starmer's NHS Turnaround Pledge 13 Sep 2026 Health Salmonella Egg Outbreak Tests UK's Food Import Safeguards 31 Aug 2026 Health Private ADHD Boom Tests NHS Diagnostic Oversight 30 Aug 2026 Health NHS Dentist Shortage Tests Access-to-Care Pledge 27 Aug 2026 ← Health UK Medical Cannabis Clinics Compared: Sapphire, Lyphe, Mamedica and Releaf Health → CBD in the UK: What Is Legal and Where to Buy